Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) announced it has received U.S. Food and Drug Administration approval for additional strengths and vial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE